T Tevogen Bio Holdings Inc.: management transactions · United States · SEC (Form 4) Browse the full management transaction log of Tevogen Bio Holdings Inc., a listed issuer based in United States. Shares trade on US US, under the authority of SEC (Form 4). Market capitalisation: €41.8m. The latest transaction was disclosed on 14 March 2025 (Cession). Among the most active insiders: Flomenberg Neal. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 14 March 2025
All Executives20 Thresholds0 Prospectus0 Other0
Declarations 20 total
▼ See Remarks · Executives · 12 Mar 2025
232,968 shares @ US$1.09 12.0% of flow Common Stock SEC:0001062993-25-005533:0
▼ See Remarks · Executives · 7 Mar 2025
71,273 shares @ US$1.14 3.9% of flow Common Stock SEC:0001062993-25-005198:0
▼ See Remarks · Executives · 4 Mar 2025
14,639 shares @ US$1.28 0.9% of flow Common Stock SEC:0001062993-25-004850:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021221:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021220:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021222:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021217:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021214:0
▼ See Remarks · Executives · 17 Oct 2024
1,078,600 shares @ US$1.62 83.2% of flow Common Stock SEC:0001062993-24-017785:0
▲ Chief Financial Officer · Executives · 12 Jun 2024
3,000 shares @ US$0.82 100.0% of flow Common Stock SEC:0001062993-24-012592:0
Ideal exit: 9 Mar 2025 (T+270) ▲ Chief Executive Officer · Executives · 5 Jun 2024
2,607.322 shares @ US$0.7671 100.0% of flow Common Stock SEC:0001062993-24-012192:0
Ideal exit: 2 Mar 2025 (T+270) ◆ Chief Commercial Officer · Executives · 14 Feb 2024
969,618 shares Common Stock SEC:0001062993-24-003489:0
◆ Director · Executives · 14 Feb 2024
581,771 shares Common Stock SEC:0001062993-24-003491:0
◆ Director · Executives · 14 Feb 2024
193,923 shares Common Stock SEC:0001062993-24-003493:0
◆ Chief Executive Officer · Executives · 14 Feb 2024
98,901,098 shares Common Stock SEC:0001062993-24-003494:0
◆ Director · Executives · 14 Feb 2024
969,618 shares Common Stock SEC:0001062993-24-003495:0
◆ Director · Executives · 14 Feb 2024
193,923 shares Common Stock SEC:0001062993-24-003496:0
◆ Chief Scientific Officer · Executives · 14 Feb 2024
5,332,902 shares Common Stock SEC:0001062993-24-003490:0
◆ Chief Financial Officer · Executives · 14 Feb 2024
9,696,186 shares Common Stock SEC:0001062993-24-003497:0
◆ Director · Executives · 14 Feb 2024
96,962 shares Common Stock SEC:0001062993-24-003492:0